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Modification of NMDA receptor function and traf-
ficking contributes to the regulation of synaptic trans-
mission and is important for several forms of synaptic
plasticity. Here, we report that NMDA receptor
subunits NR2A and NR2B have two distinct clusters
of palmitoylation sites in their C-terminal region. Pal-
mitoylation within the first cluster on a membrane-
proximal region increases tyrosine phosphorylation
of tyrosine-based internalization motifs by Src family
protein tyrosine kinases, leading to enhanced stable
surface expression of NMDA receptors. In addition,
palmitoylation of these sites regulates constitutive
internalization of the NMDA receptor in developing
neurons. In marked contrast, palmitoylation of the
second cluster in the middle of C terminus by distinct
palmitoyl transferases causes receptors to accumu-
late in the Golgi apparatus and reduces receptor
surface expression. These data suggest that regu-
lated palmitoylation of NR2 subunits differentially
modulates receptor traffickingandmightbe important
for NMDA-receptor-dependent synaptic plasticity.
INTRODUCTION
Glutamate is the major excitatory neurotransmitter in the
mammalian central nervous system. The ionotropic glutamate
receptors (GluRs) are classified into several groups, namely,
AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole propionate),
KA (kainate), d (delta), and NMDA (N-methyl-D-aspartate) recep-
tors (Hollmann and Heinemann, 1994; Seeburg, 1993). The
NMDA receptor plays a crucial role in synaptic plasticity, synap-
togenesis, and excitotoxicity (Constantine-Paton et al., 1990).
NMDA receptors consist of three families of homologous
subunits: NR1, NR2, and NR3 (Cull-Candy and Leszkiewicz,
2004; Dingledine et al., 1999; Mori and Mishina, 1995). The NR1
subunit is encoded by a single gene and is obligatory for func-
tional NMDA receptors. NR2 subunits are composed of four
members (NR2A–2D) and determine the functional and spatio-
temporal diversity of NMDA receptors. Most central NMDA
receptors are NR1/NR2 assemblies (Abe et al., 2004; Carroll
and Zukin, 2002; Wenthold et al., 2003a; Wenthold et al.,2003b). The NR1 subunit is ubiquitously expressed in neurons
throughout the brain whereas the different NR2 subunits have
more restricted patterns of distribution (Monyer et al., 1994). In
contrast to most other GluRs, NMDA receptor channels exhibit
high permeability to Ca2+ and voltage-dependent block by
Mg2+. TheNR3 subunits (NR3A andNR3B) decreaseMg2+ sensi-
tivity and Ca2+ permeability and reduce agonist-induced current
responses (Cavara and Hollmann, 2008; Cull-Candy and
Leszkiewicz, 2004). These properties underlie NMDA receptor-
dependent plasticity in the central nervous system (Collingridge
et al., 2004; Lau and Zukin, 2007; Stephenson, 2001).
Many studies have shown that posttranslational modifications
of GluRs, such as phosphorylation, play critical roles in the
regulation of synaptic plasticity (Derkach et al., 2007; Malinow
and Malenka, 2002; Shepherd and Huganir, 2007; Song and
Huganir, 2002; Swope et al., 1999). Phosphorylation of AMPA
receptors modulates AMPA receptor ion channel properties as
well as the trafficking of AMPA receptors to the postsynaptic
membrane. Similarly, phosphorylation of serine and tyrosine
residues on NMDA receptor subunits is a well-established
biochemical mechanism for the modulation of receptor function
(Collingridge et al., 2004; Lan et al., 2001; Leonard and Hell,
1997; Li et al., 2002; Nakazawa et al., 2001; Nakazawa et al.,
2006; Omkumar et al., 1996; Skeberdis et al., 2001; Vissel
et al., 2001). Another type of protein modification that regulates
localization and function of proteins is posttranslational palmi-
toylation (Bijlmakers and Marsh, 2003; El-Husseini and Bredt,
2002; Resh, 1999), the covalent attachment of palmitate to
proteins via thioester bonds at cysteine residues. Like phosphor-
ylation, this modification is labile and reversible. Posttransla-
tional palmitoylation of proteins plays important roles in the
regulation of protein targeting to membranes and synapses.
Some neuronal ionotropic receptors (Drisdel et al., 2004; Haya-
shi et al., 2005; Keller et al., 2004; Pickering et al., 1995; Rathen-
berg et al., 2004), neuronal metabotropic G protein coupled
receptors (Alaluf et al., 1995; Ng et al., 1993, 1994a, 1994b;
Ponimaskin et al., 2001, 2002), and ion channels (Chien et al.,
1996; Qin et al., 1998; Schmidt and Catterall, 1987) are reversibly
palmitoylated. We recently reported that all four types of
AMPA receptor subunits GluR1-4 are palmitoylated on two
distinct sites, in their transmembrane domain (TMD) 2 and in their
C-terminal domain (Hayashi et al., 2005). TMD 2 palmitoylation is
increased by the palmitoyl acyl transferase (PAT) GODZ and
causes accumulation of the receptor in the Golgi apparatus. Pal-
mitoylation on the C-terminal domain inhibits AMPA receptorNeuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc. 213
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receptor expression on the cell surface, and regulates endocy-
tosis and the insertion (Lin et al., 2009) of AMPA receptors.
Moreover, depalmitoylation of the AMPA receptor in neurons is
regulated by glutamate treatment. Among other ionotropic
GluRs, palmitoylation of GluR6 KA receptor has been reported
at its C-terminal cysteine residues, Cys827 and Cys840 (Picker-
ing et al., 1995). In this instance, palmitoylation regulated protein
kinase C (PKC)-mediated phosphorylation of GluR6 but did not
affect KA channel properties.
In this paper, we demonstrate that the NMDA receptor
subunits NR2A and NR2B are palmitoylated in cortical neurons
on two distinct cysteine clusters. Palmitoylation of the first
cysteine cluster (Cys cluster I) controls stable expression and
constitutive internalization of surface NMDA receptor. The
second cysteine cluster (Cys cluster II) is palmitoylated by
GODZ and depalmitoylation of this cluster regulates surface
delivery of NMDA receptors. Moreover, the palmitoylation of
the NR2 subunits is dynamically regulated by neuronal activity.
These data indicate that palmitoylation of the NR2 subunits plays
an important role in the regulation of NMDA receptor trafficking.
NMDA receptors are critical for the regulation of synaptic plas-
ticity and activity dependent development of neuronal circuits
and thus palmitoylation of the NR2 subunits might have impor-
tant effects on brain function and development.
RESULTS
Palmitoylation of the NMDA Receptor Subunits NR2A
and NR2B in Neurons
The NR1 subunit is essential for functional NMDA receptors
(Dingledine et al., 1999; Mori and Mishina, 1995). As shown in
Figure 1. Palmitoylation of Endogenous NMDA Receptor
Subunits NR2A and NR2B
(A) Palmitoylation of endogenous GluR2/3, NR2A and NR2B was
examined in metabolically labeled cultured cortical neurons. Immuno-
precipitation (IP) and detection of incorporated [3H]-palmitate into
GluR2/3 and NR2A and NR2B (top). IP and expression of each protein
was confirmed by western blotting (WB) (bottom).
(B) Hydroxylamine treatment of palmitoylated NR2A and NR2B to
confirm thioester linkage to intracellular cysteines. [3H]-palmitate
content of Tris-HCl-treated (top) and hydroxylamine (NH2OH)-treated
(middle) IP samples are shown. IP of each NR2 protein from cell
lysates of metabolically labeled cultured cortical neurons was
confirmed by WB (bottom).
(C) Palmitoylation of endogenous NR2A and NR2B was examined in
cultured cortical neurons using a biotin switch assay for palmitoylation
(Wan et al., 2007: see Experimental Procedures). Palmitoylated acyl-
biotinyl exchanged (ABE) NR2 (top) and total protein expression (cell
lysate) of NR2 protein (bottom) were confirmed by WB.
our previous work (Hayashi et al., 2005), the NR1 subunit is
not palmitoylated in cultured cortical neurons. However,
the palmitoylation status of NR2 subunits had not been
investigated. The NR2A and NR2B subunits have long
intracellular C-terminal tails, which contain many cysteine
residues. To test whether NR2 subunits were palmitoy-
lated, cultured cortical neurons weremetabolically labeled
with [3H]-palmitic acid. Metabolic labeling showed that both
endogenous NR2A and NR2B were palmitoylated (Figure 1A).
The AMPA receptor GluR2/3 subunits, which we previously
reported to bepalmitoylated,were used as a positive control. Pal-
mitoylation occurs on sulfhydryl groups of intracellular cysteine
residues in target proteins. To examine if the [3H]-palmitate was
linked to the receptor subunits via hydroxylamine-sensitive thio-
ester bonds (Bizzozero, 1995), duplicate immunoprecipitated
samples of [3H]-palmitate-labeled endogenous NR2A and NR2B
from cultured cortical neurons were treated with hydroxylamine
(NH2OH) or Tris-HCl buffer (Figure 1B). The [
3H]-palmitate labeling
of theseNR2 subunitswas eliminatedby treatmentwith hydroxyl-
amine and not by control Tris-HCl buffer, indicating that the
labeling was due to palmitoylation at cysteine residues via thio-
ester bonds. We also assessed NR2 palmitoylation in neuronal
culture using an Acyl-biotinyl exchange (ABE) assay. ABE uses
an exchange of biotin for thioester-linked acyl modifications, in
which the resultant biotinylated proteins are affinity-purified using
neutravidin-conjugatedbeads (Wanetal., 2007; seeExperimental
Procedures). This assay confirmed that bothNR2A andNR2B are
palmitoylated in cultured cortical neurons (Figure 1C).
Activity-Dependent Change of NR2 Palmitoylation
in Neurons
Previously we showed that the AMPA receptor subunits GluR1
and GluR2 were depalmitoylated when cortical neurons were
stimulated by 10 mM glutamate for 1 hr (Hayashi et al., 2005).
Using anti-NR2A and anti-NR2B antibodies, stimulation-depen-
dent changes of NR2 palmitoylation were also studied. Treat-
ment of neurons with glutamate (10 mM, 1 hr at 37C) decreased
the palmitoylation of NR2 without affecting total NR2 protein
amounts (Figures 2A and 2B). These results indicate that similar214 Neuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc.
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receptors can regulate NR2 palmitoylation. Moreover, activity-
dependent changes of NR2 palmitoylation were examined using
the biotin switch assay for palmitoylation (Figures 2C and 2D).
Treatment of neurons with tetrodotoxin (TTX, 1 mM, 30 min at
37C), to inhibit the intrinsic neuronal network, increased NR2
palmitoylation (Figure 2C), whereas treatment with bicuculline
(20 mM, 30 min at 37C), to increase the intrinsic neuronal
network activity by suppressing the inhibitory action of GABAA
receptors, conversely decreased the palmitoylation of NR2
without affecting total NR2 protein amounts (Figure 2D). These
results demonstrate that neuronal activity can dynamically regu-
late NR2 palmitoylation.
Identification of C-Terminal Palmitoylation Sites
of NR2A and NR2B
Next, we determined the sites of palmitoylation using site-
specific mutagenesis. There are 12 intracellular cysteine resi-
Figure 2. Activity-Dependent Change of Endoge-
nous NR2 Palmitoylation
(A and B) Glutamate-induced change of NR2A (A) and
NR2B (B) palmitoylation. Cultured cortical neurons were
treated with 10 mM glutamate for 1 hr at 37C. A represen-
tative example of an IP with each anti-NR2 antibody and
[3H]palmitate incorporation (top) or IP and WB with each
anti-NR2 antibody (middle) were shown. Quantified data
of ratio of [3H]palmitate-labeled NR2 to total NR2 protein
amount (bottom, left, n = 4, respectively, Student’s t
test, *p < 0.05, **p < 0.01 compared with control) and
immunoprecipitated (IP) NR2 protein amount (bottom,
right, n = 4, respectively).
(C and D) Effects of treatment with tetrodotoxin (TTX) and
bicuculline on NR2A (C) and NR2B (D) palmitoylation.
Cultured cortical neurons were treated with 1 mM TTX or
20 mM bicuculline for 30 min at 37C. A representative
example of an in vitro ABE sample, followed by purification
with streptavidin-conjugated beads and WB with each
anti-NR2 antibody is shown (top). Total protein expression
(cell lysate) of each protein was confirmed byWB (middle).
Quantified data of ratio of palmitoylated NR2 to total
NR2 protein amount (bottom, left, n = 4, respectively,
Student t test, **p < 0.01, ***p < 0.001 compared with
control) and total NR2 protein amount (bottom, right, n = 4,
respectively). Error bars indicate standard error of the
mean (SEM).
dues in NR2A and 17 in NR2B. Seven of these
sites in the intracellular C-terminal region of
NR2 subunits are conserved between NR2A
andNR2B. Of these seven conserved cysteines,
the first three cysteines (NR2A-Cys848, Cys853,
Cys870; NR2B-Cys849, Cys854, Cys871) are
located in the juxta-membrane region just past
TMD 4; we named this group of cysteine resi-
dues ‘‘Cys cluster I.’’ Another cysteine cluster,
‘‘Cys cluster II,’’ exists in the middle of NR2A/
2B C-terminal tails (NR2A-Cys1214, Cys1217,
Cys1236, Cys1239; NR2B-Cys1215, Cys1218,
Cys1239, Cys1242, Cys1245) (Figure 3A). To
test if these consensus cysteines were palmitoylated, we gener-
ated a NR2A hepta CS mutant (7CS) where all seven cysteines
in Cys cluster I and II were mutated to nonpalmitoylatable
serines (NR2AC848S/C853S/C870S/C1214S/C1217S/C1236S/
C1239S). In these experiments, the NR1-1a subunit was co-
transfected with NR2A 7CS into HEK293T cells in order to form
functional receptors (Scott et al., 2001, 2003). Labeling experi-
ments with [3H]-palmitate showed that the NR2A 7CS mutations
completely eliminated NR2A palmitoylation in transfected
HEK293T cells (Figure 3B). These data indicate that NR2A is
palmitoylated on one or more of the seven consensus cysteine
residues. To narrow down the regions of NR2A that are palmitoy-
lated, we next made a series of NR2A multiple CS mutants in
Cys cluster I (C848S/C853S/C870S) (3CS) and Cys cluster II
(C1214S/C1217S/C1236S/C1239S) (4CS). Labeling experi-
ments using these mutants showed that NR2A palmitoylation
was dramatically decreased in theNR2A3CSmutant (Figure 3C).
This result indicates that palmitoylation sites lie within aNeuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc. 215
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(A) C-terminal amino acid sequences of NMDA receptor subunits NR2A and NR2B, containing consensus cysteine clusters. Boxes indicate conserved cysteine
residues (Cys cluster I and II). Transmembrane domain (TMD) 4 is underlined. Dotted box indicates AP-2 binding motif (YXXF).
(B–E) Identification of NR2A and NR2B palmitoylation sites using a series of CS mutants. NR1/NR2A wild-type and NR1/NR2A 7CS (B), or NR1/NR2A 3CS, NR1/
NR2AC1214SC1217S, NR1/NR2AC1236SC1239S, NR1/NR2A 4CS (C), or NR1/NR2AC848S, NR1/NR2AC853S, NR1/NR2AC870S, NR1/NR2AC848SC853S,
NR1/NR2A 3CS (D), and NR1/NR2B wild-type and NR1/NR2B 3CS (E) were cotransfected into HEK293T cells. Transfected cells were metabolically labeled
with [3H]-palmitate and then solubilized and lysates were immunoprecipitated with anti-NR2A or anti-NR2B antibodies. The incorporated [3H]-palmitate signals
were shown (upper top). Immunoprecipitation (IP, second panels) and total protein expression (cell lysate) of each protein (third and fourth panels) was confirmed
by WB.homologous C-terminal region just after the TMD 4 (Cys cluster
I). Finally, we determined the exact cysteines that were palmitoy-
lated in NR2A subunit. In an experiment using a series of
CS mutants within the Cys cluster I (C848S, C853S, C870S,
C848S/C853S, 3CS), we detected palmitoylation signals in
each single CS mutant and even in double CS mutant (C848S/
C853S). Palmitoylation was eliminated only when all three cyste-
ines were mutated in the 3CS mutant, suggesting that each of
the three cysteines within the Cys cluster I can be palmitoylated
in HEK293T cells (Figure 3D). The NR2B triple CS mutant (3CS),
whose corresponding cysteine residues in Cys cluster I were216 Neuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc.substituted with serine (C849S/C854S/C871S), was not palmi-
toylated, similar to NR2A (Figure 3E). These data indicate that
both NR2A and NR2B are palmitoylated in their Cys cluster I.
With longer exposures, a weak [3H]-palmitate signal was
detected in the NR2A 3CS and NR2B 3CS mutant, suggesting
that NR2A and NR2B contains additional minor palmitoylation
site(s) (data not shown). Coimmunoprecipitation experiments in
transfected HEK293T cells showed that CS mutations in both
Cys cluster I and II did not affect the proper assembly of the
NR1 with either NR2A subunits (see Figure S1A available online)
or NR2B subunits (Figure S1B).
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Dual Palmitoylation Regulates NMDAR TraffickingFigure 4. Palmitoylation of NR2A and NR2B by the Palmitoyl Acyl Transferase GODZ
(A) Palmitoylation of NR2A C terminus in NR1/NR2A and NR1/NR2A 3CS by cotransfected palmitoyl acyl transferase GODZ or its inactive mutant GODZ(DHHS).
(B) Palmitoylation of NR2A in NR1/NR2A and NR1/NR2A 4CS by cotransfected GODZ or GODZ(DHHS).
(C) Palmitoylation of NR2A in NR1/NR2A and NR1/NR2A 7CS by cotransfected GODZ or GODZ(DHHS).
(D) Palmitoylation of NR2B in NR1/NR2B, NR1/NR2B 3CS, NR1/NR2B 5CS andNR1/NR2B 8CS by cotransfected GODZ or GODZ(DHHS). Transfected HEK293T
cells were labeled with [3H]-palmitate and were then immunoprecipitated with anti-NR2A or anti-NR2B antibodies. The incorporated [3H]-palmitate signals were
shown (upper top). Immunoprecipitation (IP, upper bottom) and total protein expression (cell lysate) of each protein (lower panels) were confirmed by WB.Palmitoylation of the NR2 in Its C-Terminal Region
by GODZ
PATs were originally cloned by genetic studies in yeast (Erf2,
Akr1, and Ykt6) (Dietrich et al., 2004; Dietrich and Ungermann,
2004; Lobo et al., 2002; Roth et al., 2002). Erf2 and Akr1 have
an aspartate-histidine-histidine-cysteine (DHHC)-cysteine rich
domain, which is conserved in proteins from yeast to mammals.
A large family of mammalian DHHC-PATs, 23 in mouse and 22 in
human, has been identified (Fukata et al., 2004; Huang et al.,
2004; Ohno et al., 2006). A Golgi apparatus-specific protein
with a DHHC zinc finger domain (GODZ) has been reported to
have PAT activity toward both AMPA and GABAA receptors
(Hayashi et al., 2005; Keller et al., 2004; Uemura et al., 2002).
We therefore examined if GODZmight also function as a neuronal
PAT for the NMDA receptor. Palmitoylation of NR2A was
enhanced by coexpression of GODZ in transfected HEK293T
cells (Figure 4A). In contrast, the catalytically inactive mutant of
GODZ (DHHS) (Hayashi et al., 2005) did not cause this increase
(Figure 4A). However, although mutation of NR2A Cys cluster I
(3CS) decreased NR2A palmitoylation, it did not eliminate palmi-
toylation of NR2A in the presence of GODZ. These results indi-
cate that GODZ palmitoylates NR2A at additional sites besides
the Cys cluster I (Figure 4A). Mutation of cluster II (NR2A 4CS)
decreased palmitoylation, indicating that GODZ palmitoylatesCys cluster II (Figure 4B). A low level of palmitoylation of NR2A
was still seen in the NR2A 7CS mutant, indicating that GODZ
also palmitoylates sites outside of Cys cluster I and II (Figure 4C).
Similar resultswere obtainedwithNR2B3CS, a penta-CSmutant
of Cys cluster II (5CS) and octa-CS mutant on Cys cluster I and II
(8CS) (Figure 4D). These data indicate that overexpression of
GODZ catalyzes palmitoylation of cluster II in both the NR2A
andNR2Bsubunits. GODZhad no effect onGluR6palmitoylation
(Figure S2A). Endogenous GODZ expression in both 11 DIV and
22 DIV cultured cortical neurons was confirmed by western blot-
ting with anti-GODZ antibodies (Figure S2B).
Palmitoylation-Dependent Tyrosine Phosphorylation
of NR2
The functional effect of palmitoylation of NR2A and NR2B was
initially examined in heterologous cells. Conserved membrane-
proximal motifs in the C terminus of NR2A (Y842WKL) and
NR2B (Y843WQF), directly adjacent to Cys cluster I are neces-
sary and sufficient to drive the internalization of NMDA receptors
(Figure 3A) (Lau and Zukin, 2007; Scott et al., 2004). These
regions contain a consensus binding motif (YXXF, F represents
a large hydrophobic residue) for the m2 subunit of the clathrin
adaptor protein AP-2. Previous studies have shown NR2A
surface expression is regulated by Src protein tyrosine kinaseNeuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc. 217
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2001). Tyrosine dephosphorylation triggers stimulation-depen-
dent NMDA receptor internalization. We therefore investigated
whether palmitoylation of Cys cluster I might affect tyrosine
phosphorylation of NR2A and thus regulate receptor surface
expression. NR1/NR2A or NR1/NR2A 3CS were cotransfected
into HEK293T cells with or without the Src family PTK Fyn and
tyrosine phosphorylation of NR2A subunit was examined by
immunoblotting with anti-phosphotyrosine antibody (PY20).
The result showed that Fyn-dependent tyrosine phosphorylation
of wild-type NR2A was markedly higher than that of the NR2A
Cys cluster I (3CS) mutant (Figure 5A). There was no significant
change of tyrosine phosphorylation between NR2A wild-type
and NR2A 4CS mutant, indicating that Fyn-mediated tyrosine
phosphorylation of NR2A was not affected by palmitoylation in
Cys cluster II (Figure S1C).
We also examined tyrosine phosphorylation of NR2B and
NR2B 3CS mutant by Fyn in transfected HEK293T cells
(Figure 5B). The Fyn-dependent tyrosine phosphorylation of
the wild-type NR2B subunit, similar to NR2A, was markedly
higher than that of the NR2B 3CS mutant. NR2B contains an
additional YXXF motif in its C terminus (Y1472EKL) and this
Tyr1472 is the major tyrosine phosphorylation site in NR2B for
Src family PTKs. Activity-dependent phosphorylation of NR2B
at Tyr1472 by Fyn PTK suppresses clathrin-mediated endocy-
tosis of NMDA receptors (Nakazawa et al., 2001; Prybylowski
et al., 2005; Yaka et al., 2002). Fyn-dependent phosphorylation
of Tyr1472 is also required for proper localization of NR2B-con-
taining receptors at synapses in the hippocampus (Prybylowski
et al., 2005) and amygdala (Nakazawa et al., 2006). We therefore
also examined tyrosine phosphorylation of Tyr1472 of the wild-
type and NR2B 3CS mutant. Immunoblotting with site-specific
phosphoantibodies revealed that Fyn-dependent phosphoryla-
tion of NR2B Tyr1472 was decreased in the NR2B 3CS mutant.
Interestingly, phosphorylation of NR2B on Tyr1252 was not
altered in the NR2B 3CS mutant. These results suggest that pal-
mitoylation of Cys cluster I might influence the NR2B C-terminal
structure and the accessibility of Src family PTKs to their
substrates, or might regulate Src family PTKs association with
the C-terminal region. There was no significant change of tyro-
sine phosphorylation between NR2B wild-type and NR2B 5CS
mutant, indicating that Fyn-mediated tyrosine phosphorylation
of NR2B was not affected by palmitoylation in Cys cluster II
(Figure S1D).
To investigate the influence of NR2 palmitoylation on tyrosine
phosphorylation dependent internalization of the NMDA
receptor, NR1/NR2A and NR1/NR2A 3CS were cotransfected
into HEK293T cells with or without Fyn (Figure 5C). Surface
expressing NR1 was immunostained with polyclonal anti-NR1
N-terminus antibodies at 4C for 1 hr and returned to 37C for
15 min. Cells were then fixed and permeabilized, and total NR1
was stained with monoclonal anti-NR1 C-terminal antibody.
Total NR1 expression and the internalized anti-NR1 N-terminus
antibodies were visualized by staining with fluorescent-conju-
gated secondary antibodies. The ratio of the average intensity
of internalized anti-NR1 antibodies (Alexa594-red intensity) to
that of total NR1 level (Alexa488-green intensity) was calculated.
The results showed that Fyn inhibited NR1/NR2A endocytosis,218 Neuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc.but Fyn had less effect on NR1/NR2A 3CS (Figure 5C). These
data indicated that NR2A palmitoylation upregulates Src family
PTKs-dependent tyrosine phosphorylation of NR2A and inhibits
consequent AP-2 mediated internalization of NMDA receptors.
Regulation of NMDA Receptor Surface Expression
by C-Terminal Palmitoylation in Neurons
We next investigated whether palmitoylation affected the
steady-state membrane trafficking of the NMDA receptor in
neurons. We initially examined the steady-state surface expres-
sion of N-terminally GFP-tagged NR2B (GFP-NR2B WT) and its
palmitoylation-deficient mutant on Cys cluster I (GFP-NR2B
3CS) in neurons. These constructs were transfected into
cultured cortical neurons at 9 days in vitro (DIV) and examined
2 days after transfection at 11 DIV. Phosphorylation at Tyr1472
of GFP-NR2BWT and 3CSmutant were examined in transfected
neurons (Figure 6A). Tyrosine phosphorylation of GFP-NR2BWT
was higher than that of GFP-NR2B 3CS, similar to the result of
Fyn-dependent NR2B phosphorylation in transfected HEK293T
cells (Figure 5B). Surface expression of GFP-NR2B WT and
GFP-NR2B 3CSmutant was visualized by live staining with poly-
clonal anti-GFP antibodies, followed by addition of Alexa594-
conjugated anti-rabbit immunoglobin G (IgG) secondary anti-
bodies. Representative patterns of GFP-NR2B WT and its
GFP-NR2B 3CS mutant are shown (Figure 6B). The ratio of
Alexa594 to GFP fluorescence intensities indicated the propor-
tion of surface to total GFP-NR2B. Compared with GFP-NR2B
WT, the GFP-NR2B 3CS mutant showed decreased levels of
surface expression (Figure 6C). Similar results were observed
in older cultured cortical neurons (22 DIV), which were trans-
fected at 16 DIV and examined for surface expression 6 days
after transfection (Figure 6D). Moreover, N-terminally GFP-
tagged NR2A (GFP-NR2A WT) had a higher level of surface
expression than its Cys cluster I mutant (GFP-NR2A 3CS) in
cultured cortical neurons at 22 DIV (Figure S3A). These results
suggest that steady-state surface expression of NMDA recep-
tors is influenced by palmitoylation on Cys cluster I of NR2A
and NR2B in neurons.
Palmitoylation-Dependent NMDA Receptor Constitutive
Internalization in Developing Neurons
Unlike AMPA receptors, synaptic NMDA receptors are stable
components of the postsynaptic density. However, surface-
expressed NMDA receptors have been shown to internalize in
primary cultured neurons, especially early in development (Lav-
ezzari et al., 2004; Roth et al., 2002). At early stages of develop-
ment, NMDA receptors undergo robust endocytosis, which
progressively decreases in more mature cultures (Roche et al.,
2001). We therefore examined the effects of the Cys cluster I pal-
mitoylation on constitutive internalization of surface NR2B.
Surface expression of the GFP-NR2B WT and the GFP-NR2B
3CS mutant in transfected cortical neurons were labeled by
live staining with anti-GFP antibodies and the neurons were
then incubated in media for 15 min at 37C. After incubation,
the neurons were fixed, and the internalized anti-GFP antibodies
were visualized by stainingwith Alexa594-conjugated secondary
antibodies. The ratio of the average intensity of internalized
anti-GFP antibodies to that of surface GFP-NR2B level was
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Dual Palmitoylation Regulates NMDAR TraffickingFigure 5. Palmitoylation Regulates Tyrosine Phosphorylation of NR2A and NR2B by the Src Family Tyrosine Kinase Fyn
(A) Fyn-mediated tyrosine phosphorylation of NR2A in NR1/NR2A and NR1/NR2A 3CS receptors. HEK293T cells were cotransfected with NR2A or NR2A 3CS
and NR1 in the presence or absence of Fyn. Transfected cells were solubilized and then immunoprecipitated with anti-NR2A antibodies, and were then probed
with phosphotyrosine antibody (PY20) (upper top panel). Immunoprecipitation (IP, upper bottom) and total protein expression (cell lysate) of each protein (lower
panels) were confirmed by WB.
(B) Fyn-mediated tyrosine phosphorylation of NR2B and NR2B 3CS. The phosphotyrosine signals (PY20) were shown (upper top). IP of NR2B (top), site-specific
tyrosine phosphorylation (NR2BpY1472 and NR2BpY1252, middle), and total protein expression (cell lysate) of each protein (bottom) were confirmed by WB.
(C) Effect of Fyn on NMDA receptor endocytosis in transfected HEK293T cells. Representative patterns of total and constitutive internalized NR1 were shown
(top). The ratio of fluorescence intensities of internalized anti-NR1 antibodies to total NR1 expression in transfected HEK293T cells is shown (bottom, four
bars: NR1/NR2A, NR1/NR2A/Fyn, NR1/NR2A 3CS, and NR1/NR2A 3CS/Fyn; n = 22, n = 28, n = 29, n = 34 cells, respectively; F = 5.276, p < 0.002, ANOVA).
***p < 0.001 compared with combination without Fyn. Error bars indicate SEM.calculated. Constitutive internalization of GFP-NR2B WT was
lower than that of the palmitoylation-deficient GFP-NR2B 3CS
mutant in young neurons (11 DIV) (Figure 6E). To examine
whether tyrosine phosphorylation interacted with this palmitoy-
lation-regulated internalization in neurons as predicted fromour HEK293T cells, we used the Src family PTK-specific inhibitor
PP2. Constitutive internalization of GFP-NR2B WT at 11 DIV
was enhanced by the Src family PTK-specific inhibitor PP2,
compared with its inactive structural analog PP3. In contrast,
PP2 had little effect on constitutive internalization of GFP-NR2BNeuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc. 219
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on its Cys cluster I regulates constitutive endocytosis of NMDA
receptors during synaptic development, most likely by regulat-
ing tyrosine phosphorylation of tyrosine-based internalization
motifs.
Palmitoylation-Dependent Regulation of Src Family
PTK-Mediated NMDA Receptor Surface Expression
Finally, we tested the influence of palmitoylation of Cys cluster I
on Src family PTK-mediated NR2B surface expression. The
GFP-NR2B WT and the GFP-NR2B CS mutant were transfected
into cultured cortical neurons at 9 DIV. At DIV 11 the neurons
were treated with Src family PTK-specific inhibitor PP2 (20 mM)
or its inactive structural analog PP3 (20 mM) and receptor surface
expression was examined. Surface expression of GFP-NR2B
WT was decreased by PP2 treatment (Figure 6F). In contrast,
surface expression of GFP-NR2B 3CS was not affected by
PP2. Similar results were observed in older cultured cortical
neurons at 22 DIV (Figure 6G), which were transfected at 16 DIV
and examined for surface expression 6 days after transfection.
Nonpalmitoylated NR2B was less tyrosine phosphorylated
(Figure 5B) and Src family PTK had little effect on surface expres-
sion of NR2B 3CS mutant. In addition, PP2 treatment showed
similar effects on GFP-NR2A WT, but not on GFP-NR2A 3CS,
in cultured cortical neurons at 22 DIV (Figure S3B). This result
suggests that NR2 internalization through tyrosine-based
internalization motif in the membrane proximal region (Vissel
et al., 2001) is also regulated by palmitoylation on Cys cluster I.
The Src family PTK-specific inhibitors PP2 (Figure S3D) and
SU6656 (Figure S3E) also suppressed the surface expression
of endogenous NR2A. These data indicated that palmitoylation
on Cys cluster I regulated Src family PTK-mediated tyrosine
phosphorylation of NR2A and NR2B and surface expression of
NMDA receptors.
Accumulation of Cys Cluster II-Palmitoylated NR2
in the Golgi Apparatus
We next examined the effect of GODZ on NR2 subcellular local-
ization using immunocytochemical techniques. Our previous
data showed that both GODZ and its catalytically inactive
mutant, GODZ (DHHS), colocalized with the Golgi-apparatus
marker GM-130 and were concentrated in the Golgi apparatus
in transfected HEK293T cells (Hayashi et al., 2005) (see Figure 7).
Cotransfection of NR1 and NR2A in HEK cells results in a diffuse
localization of NR2A. However, cotransfection of NR1/NR2A
with GODZ resulted in the NR2A subunit being localized with
GODZ in the Golgi apparatus. In contrast, cotransfection of
NR1/NR2A with the catalytically inactive GODZ (DHHS) mutant,
Figure 6. Effect of CysCluster I Palmitoylation of NR2Bon
the Steady-State Surface Expression and Constitutive
Internalization of NMDA Receptors
(A) Phosphorylation at Tyr1472 of GFP-NR2B WT and GFP-NR2B
3CS transfected cultured cortical neurons.
(B) Representative patterns of surface expression of GFP-NR2B
WT and GFP-NR2B 3CS mutant in transfected cultured cortical
neurons. Total GFP-NR2B distribution (top) and surface expres-
sion of GFP-NR2B (bottom) were shown.
(C) Ratio of surface to total expression of GFP-NR2B at 11 DIV
(WT and 3CS, n = 16 neurons, respectively). Student t test. **p <
0.01 compared with WT.
(D) Ratio of surface to total expression of GFP-NR2B at 22 DIV
(WT and 3CS, n = 16 neurons respectively). Student t test. **p <
0.01 compared with WT.
(E) Regulation of NR2B constitutive internalization by its palmitoy-
lation on Cys cluster I. The effect of Src family PTK-specific inhib-
itor PP2 (20 mM) or the inactive structural analog PP3 (20 mM) on
internalization of GFP-NR2B WT (WT) and GFP-NR2B 3CS (3CS)
in transfected cultured cortical neurons at 11 DIV (n = 12 neurons,
respectively). Cultured cortical neurons were treated with PP2 or
PP3 for 30 min and the ratio of fluorescence intensities of internal-
ized anti-GFP antibodies to surface GFP expression of GFP-NR2B
was examined. ***p < 0.001.
(F and G) Effects of treatment with Src family PTK specific inhibitor
PP2 (20 mM) and its inactive analog PP3 (20 mM) for 30 min on
steady-state surface expression of GFP-NR2B WT and GFP-
NR2B 3CS in transfected cultured cortical neurons were exam-
ined. (F) Ratio of surface to total GFP expression of GFP-NR2B
at 11 DIV (four bars [WT+PP3, WT+PP2, 3CS+PP3, 3CS+PP2],
n = 12 neurons, respectively, F = 9.837, p < 0.0001, ANOVA).
*p < 0.05 compared with PP3 treatment. (G) Ratio of surface to
total GFP expression of GFP-NR2B at 22 DIV (four bars
(WT+PP3, WT+PP2, 3CS+PP3, 3CS+PP2), n = 12 neurons
respectively, F = 27.90, p < 0.0001, ANOVA). ***p < 0.001
compared with PP3 treatment. Error bars indicate SEM.220 Neuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc.
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(A) Colocalization of NR2A with Golgi-apparatus marker GM-130 in HEK293T cells cotransfected with NR1 and NR2A with or without myc-GODZ or myc-
GODZ(DHHS) (upper panels) and with NR1 and NR2A 4CS with or without myc-GODZ or myc-GODZ(DHHS) (lower panels).
(B) Colocalization of NR2A with GODZ in HEK293T cells cotransfected with NR1 and NR2A with myc-GODZ or myc-GODZ(DHHS) (upper panels) and with NR1
and NR2A 4CS with myc-GODZ or myc-GODZ(DHHS) (lower panels).
(C) Colocalization of NR2B with Golgi-apparatus marker GM-130 in HEK293T cells cotransfected with NR1 and NR2B with or without myc-GODZ or myc-
GODZ(DHHS) (upper panels) and with NR1 and NR2B 5CS with or without myc-GODZ or myc-GODZ(DHHS) (lower panels).
(D) Colocalization of NR2B with GODZ in HEK293T cells cotransfected with NR1 and NR2B with myc-GODZ or myc-GODZ(DHHS) (upper panels) and with NR1
and NR2B 5CS with myc-GODZ or myc-GODZ(DHHS) (lower panels).or cotransfection of NR1 and the Cys cluster II mutant, NR2A
4CS, with GODZ, resulted in a diffuse distribution of NR2A in
cells (Figure 7A). The majority of NR2A was colocalized with
GODZ when these proteins were coexpressed (Figure 7B, upperpanels). Moreover, NR2A accumulated with NR1 in the Golgi
apparatus (Figures S4A and S4B), while in contrast, the Cys
cluster II mutant, NR2A 4CS, did not colocalize with GODZ
(Figure 7B, lower panels). Similar results were obtained for theNeuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc. 221
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the Cys cluster I mutants, NR2A 3CS (Figures S4C and S4D)
and NR2B 3CS (Figures S4E and S4F), behaved similarly to
wild-type NR2 subunits and colocalized with GODZ in the
Golgi apparatus. These data demonstrate that palmitoylation
of the NR2A and NR2B subunits on Cys cluster II, but not Cys
cluster I, leads to accumulation of the receptor in the Golgi appa-
ratus and suggests that Cys cluster II depalmitoylation might
trigger receptor trafficking to the cell surface.
Suppression of NMDA Receptor Surface Expression
by GODZ-Regulated Palmitoylation
As shown above, GODZ-mediated palmitoylation of Cys cluster
II causes NR2 to localize to the Golgi apparatus in transfected
heterologous cells. To examine whether this regulation also
occurred in neurons, we analyzed whether GODZ suppressed
the surface expression of endogenous NMDA receptors in
cultured cortical neurons (Figure 8A). Cultured cortical neurons
were transfected with GODZ-GFP or GODZ(DHHS)-GFP and
surface expression of endogenous NR2A was measured by
live staining with polyclonal anti-NR2A N-terminal antibodies,
followed by labeling with Alexa594-conjugated anti-rabbit IgG
Figure 8. GODZ-Mediated Suppression of NR2
Surface Expression through its Palmitoylation on
Cys Cluster II
(A) Surface expression of endogenous NR2A in GODZ-GFP
transfected cultured cortical neurons. Typical expression
patterns of surface NR2A and GODZ-GFP or GODZ(DHHS)-
GFP were shown (left). Quantified data of surface expression
of endogenous NR2A in transfected cultured cortical neurons
at 21 DIV (right, n = 10 neurons, respectively, Student’s t test.
***p < 0.001 compared with control.
(B) Ratio of surface to total GFP expression of GFP-NR2B at
11 DIV (WT and 5CS, n = 16 neurons, respectively).
(C) Ratio of surface to total GFP expression of GFP-NR2B at
22 DIV (WT and 5CS, n = 16 neurons, respectively). Student’s
t test. *p < 0.05 compared with WT.
(D) Effect of myc-GODZ or myc-GODZ(DHHS) inactive mutant
on surface expression of GFP-NR2B in transfected cultured
cortical neurons at 11 DIV. Ratio of surface to total GFP
expression of GFP-NR2B at 11 DIV (WT and 5CS, n = 16
neurons, respectively). Student’s t test. *p < 0.05 compared
with WT. Error bars indicate SEM.
antibodies. Although GODZ (DHHS) mutant had
no effect on NR2A surface expression, wild-type
GODZ dramatically reduced NR2A surface expres-
sion (Figure 8A). These data suggest that GODZ-
induced palmitoylation on Cys cluster II region of
NR2 subunits inhibits NMDA receptor surface
expression in neurons.
Finally, we examined the steady-state surface
expression of GFP-NR2B WT and its palmitoyla-
tion-deficient Cys cluster II mutant, GFP-NR2B
5CS, in neurons. Compared with GFP-NR2B WT,
the GFP-NR2B 5CS mutant showed increased
levels of surface expression both at 11 DIV (Fig-
ure 8B) and at 22 DIV (Figure 8C). Moreover, the
GFP-NR2A 4CS mutant also showed increased surface expres-
sion in cultured cortical neurons compared with the GFP-NR2A
WT (Figure S3C). The increased surface expression of the non-
palmitoylated GFP-NR2A 4CS and GFP-NR2B 5CS supports
the hypothesis that Cys cluster II depalmitoylation promotes
forward trafficking of NMDA receptors to the cell surface. The
surface expression of GFP-NR2B WT was reduced by cotrans-
fectedGODZ, but not by inactive GODZ(DHHS)mutant, whereas
that of GFP-NR2B 5CS was not influenced by GODZ or
GODZ(DHHS) (Figure 8D). Similar results were obtained with
GFP-NR2A WT and GFP-NR2A 4CS (Figure S3F).
DISCUSSION
Here, we report that the NMDA receptor subunits NR2A and
NR2B are palmitoylated in vitro and in vivo. The NR2A and
NR2B subunits, which are predominantly expressed in forebrain
with characteristic but overlapping distribution profiles, have two
distinct consensus cysteine clusters in their C terminus (Cys
clusters I and II). Surface expression of the NMDA receptor
was regulated by dual palmitoylation of these sites (Figure 9).
In particular, palmitoylation of Cys cluster I controls NMDA222 Neuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc.
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modulating tyrosine phosphorylation of NR2A and NR2B. Under
basal conditions, internalization of NMDA receptors occurs
through clathrin-mediated endocytosis, primarily by interactions
between AP-2 and tyrosine based internalization motifs (YXXF)
(Carroll and Zukin, 2002; Lau and Zukin, 2007; Prybylowski
et al., 2005). Tyrosine phosphorylation within these motifs by
Src family PTK eliminates AP-2 binding. We found that Fyn-
mediated tyrosine phosphorylation of NR2A and NR2B was
reduced in the NR2A 3CS and NR2B 3CS nonpalmitoylation
mutants. Our data indicate that Fyn-mediated phosphorylation
of tyrosine based internalization motifs in membrane proximal
regions is increased by palmitoylation of the adjacent Cys cluster
I. In addition, tyrosine phosphorylation at NR2B Tyr1472, a major
site for Fyn phosphorylation, is also decreased by mutation of
Cys cluster I. Palmitoylation-dependent phosphorylation at
NR2B Tyr1472 presumably induces AP-2 dissociation from tyro-
sine based internalization motif. Moreover, Cys cluster I palmi-
toylation-dependent and tyrosine phosphorylation-dependent
effects on constitutive rapid internalization were observed in
neurons. In contrast, palmitoylation of Cys cluster II by GODZ
regulates the accumulation of NMDA receptors in the Golgi
apparatus and depalmitoylation of these cysteines might be
Figure 9. Model of the Role of NMDA Receptor Palmitoylation
(A) GODZ increases palmitoylation of NMDA receptors on the NR2A/2B
subunit Cys cluster II region ([II] palm-NR2) in Golgi apparatus. Depalmitoyla-
tion of the NR2A/2B subunit Cys cluster II might regulate release of NMDA
receptors from the Golgi for surface delivery as shown by black arrow.
(B) Palmitoylation of the NMDA receptor on the NR2A/2B subunit Cys cluster I
([I] palm-NR2) ensures proper surface delivery and increases the stability of
NMDA receptors on the cell surface via tyrosine phosphorylation of tyrosine
based internalization motifs (pY). In contrast, depalmitoylated forms of surface
NMDA receptors are less stably associated with the plasmamembrane. Palmi-
toylation is reversible between these two forms as shown by white arrows.
(C) Palmitoylation on Cys cluster I ([I] palm-NR2) allows rapid constitutive inter-
nalization from surface in developing neurons as shown by slashed arrow.critical for release of the receptor from the Golgi for surface
delivery. The mechanism of this Golgi retention is not clear but
might require a palmitoylation specific interaction of the NR2
subunits with Golgi-specific proteins.
Other NR2 subunits, NR2CandNR2D, carry shorter C-terminal
domains. NR2C, containing 16 intracellular cysteines, is the
predominant NR2 subunit in cerebellum and has only one
cysteine (Cys866) that shares homology to any of the palmitoy-
lated cysteines in NR2A and NR2B (Figure S5). The expression
of NR2Doccursmainly in themidbrain and spinal cord and peaks
around postnatal day 7 and decreases thereafter (Monyer et al.,
1994). The NR2D subunit has 12 intracellular cysteine residues
and has two cysteines (Cys873 and Cys893) that are conserved
at the corresponding sites with NR2A Cys848/Cys870 and
NR2BCys849/Cys871 in Cys cluster I. The amino acid sequence
around NR2DCys1168 and Cys1171 has low homology with first
two cysteines in NR2A/2B Cys cluster II. It is possible that local-
ization and trafficking of NR2C- or NR2D-containing NMDA
receptors might also be regulated by palmitoylation of these
partially conserved cysteines.
We previously reported that all AMPA receptor subunits
(GluR1-4) are palmitoylated (Hayashi et al., 2005). The AMPA
receptor subunits GluR1-4 also have two distinct palmitoylation
sites, one in their TMD 2 region and one in their C-terminal
domain. Similar to GODZ palmitoylation of cluster II in the
NR2 subunits, the palmitoylation of TMD 2 by GODZ retains
AMPA receptors in the Golgi apparatus. Depalmitoylation of
the TMD 2 site is presumably a trigger for the receptor surface
delivery. In contrast, C-terminal depalmitoylation of the AMPA
receptor GluR1 subunit stabilizes the receptor surface expres-
sion through interacting molecules such as protein 4.1N. Amino
acid sequences around these palmitoylation sites are not
conserved between GluR1-4 and NR2A/2B. Interestingly, the
trafficking of AMPA receptors and NMDA receptors occurs in a
palmitoylation-dependent two-stepmanner (Figure S6). Namely,
the Golgi localized PAT GODZ regulates GluR accumulation
in Golgi apparatus through a palmitoylation site (TMD 2 in
GluR1-4 or Cys cluster II in NR2A/2B), whereas palmitoylation
of the C-terminal domain in AMPA receptors or Cys cluster I in
NMDA receptors regulates the stability of the receptors on the
surface plasma membrane. Although palmitoylation of AMPA
and NMDA receptors both have effects on receptor trafficking,
the modulation of these two receptors would have distinct
impacts on neuronal function.Modulation of AMPA receptor traf-
fickingwould directly affect the strength of synaptic transmission
whereas modulation of NMDA receptor function would affect
NMDA receptor-dependent plasticity and activity-dependent
development.
Localization and trafficking of GluRs, as well as their ion
channel properties, are regulated by posttranslational protein
modifications. The most well-established posttranslational
protein modification of GluRs is phosphorylation. Previous
studies have shown that channel properties and trafficking
of NMDA receptors were regulated by phosphorylation of
both NR1 and NR2 subunits (Collingridge et al., 2004). In this
study, we revealed a novel regulatory mechanism of NMDA
receptor trafficking by dual palmitoylation of NR2 subunits.
Interestingly, NR2 palmitoylation is dynamically regulated inNeuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc. 223
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subunits regulates NMDA receptor membrane trafficking. Palmi-
toylation of Cys cluster I regulates NMDA receptor internalization
whereas palmitoylation of Cys cluster II retains the receptor in
the Golgi apparatus. The dynamic regulation of NR2 palmitoyla-
tion by neuronal activity might profoundly affect the plasma
membrane and synaptic localization of NMDA receptors critical
for the regulation of NMDA receptor-dependent plasticity and
development.
EXPERIMENTAL PROCEDURES
Primary Neuron Culture, HEK293T Cells, and Transfection
High-density cultured cortical neurons were prepared as previously described
(Hayashi and Huganir, 2004). Cultured cortical neurons (106 cells per lane)
were used between 3 and 4 weeks after plating for biochemical experiments.
At indicated DIV, cultured cortical neurons on coverslips were used for GFP-
NR2A/2B wild-type or CS mutants transfection using Lipofectamine 2000.
HEK293T cells (107 cells per lane) were transfected with wild-type and CS
mutants of pcDNA1-NR2A, pRK5-NR2B, and pRK5-NR1-1a, or pRK5-GluR6
with or without pcDNA3-myc-GODZ and pcDNA3-myc-GODZ(DHHS), or
pME18S-Fyn (CMV promoter) using a calcium phosphate method.
Analysis of Palmitoylation
HEK293T cells were transiently transfected with NR1/NR2 and Myc-tagged
GODZ and metabolically labeled with [3H]palmitate (NEN, 1 mCi/ml) for 4–5 hr,
2 days after transfection. Cells were lysed in RIPA buffer (containing 10 mM
Tris-HCl [pH 7.3], 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS,
and 0.1% sodium deoxycholate, 10 mg/ml aprotinin, and 10 mg/ml leupeptin
with 1 mM Na3VO4 and 1 mM NaF for tyrosine phosphorylation experiments)
and immunoprecipitated with anti-NR2A (JH5524 and JH5525) and anti-
NR2B (JH5522 and JH5523) antibodies. Immunoprecipitated samples and
total cell lysates were separated by 7.5% SDS-PAGE followed by western
blotting or X-ray film exposure, respectively. For fluorography, gels were fixed
with 50% methanol, 10% acetic acid at room temperature for 30 min, treated
with Amplify solution (Amersham) for 30 min, dried under vacuum, and
exposed to Hyperfilm-MP (Amersham) at 80C. Protein expression was
confirmed by western blotting with each antibody (anti-NR1 (JH4762), anti-
Myc (9E10) antibodies). Anti-phosphotyrosine (PY20) antibody was purchased
from Santa Cruz. Anti-NR2B pY1472 and anti-NR2B pY1252 antibodies were
purchased from PhosphoSolutions. Anti-GODZ antibodies were purchased
from Chemicon.
Cultured cortical neurons were metabolically labeled with [3H]palmitate
(1 mCi/ml) for 24 hr. Neurons were lysed in RIPA buffer and immunoprecipi-
tated with anti-GluR2/3 (JH4854), anti-NR2A or anti-NR2B antibodies. In the
hydroxylamine treatment experiment, duplicate gels of labeled NR2A and
NR2B, purified from cultured cortical neurons, were treated with 1 M hydrox-
ylamine (NH2OH, pH 7.0) or control 1 M Tris-HCl (pH 7.0) for 18 hr at room
temperature, followed by exposure to film as above. Then 10% of total immu-
noprecipitated NR2 was used for western blotting with anti-NR2 antibodies to
confirm the immunoprecipitated NR2 and 90% was used for [3H]palmitate-
labeled signal exposure. Data were representative of more than three experi-
ments. NMDA receptor palmitoylation was also assessed using acyl-biotinyl
exchange (Drisdel et al., 2006; Kang et al., 2008). The method of Wan et al.
was followed, except that cultured cortical neurons were directly denatured
in Lysis buffer (50 mM HEPES [pH 7.0], 2% SDS, 1 mM EDTA plus protease
inhibitor cocktail [Roche] containing 20 mM methyl methanethiosulfonate to
block free thiols) and acetone precipitation was used to move between steps.
Following lysis, excess MMTS was removed by three sequential acetone
precipitations and pellets were resuspended in buffer containing 4% (w/v)
SDS (‘‘4SB’’; Wan et al., 2007). Samples were diluted and incubated for 1 hr
in either 0.7 M hydroxylamine (pH 7.4) (to cleave thioester bonds) or 50 mM
Tris (pH 7.4). Three acetone precipitations were performed to remove hydrox-
ylamine or Tris. Pellets were resuspended in 4SB, diluted in 50mMTris (pH 7.4)
containing sulfhydryl-reactive (HPDP-) biotin, and incubated for 1 hr at room224 Neuron 64, 213–226, October 29, 2009 ª2009 Elsevier Inc.temperature. Three acetone precipitations were performed to remove
unreacted HPDP-biotin and pellets were resuspended in lysis buffer without
MMTS. SDSwas diluted to 0.1% (w/v) and biotinylated proteins in the samples
were affinity-purified using neutravidin-conjugated beads. Beta-mercaptoe-
thanol (1% v/v) was used to cleave HPDP-biotin and release purified proteins
from the beads. The released proteins in the supernatant were denatured in
SDS sample buffer and processed for western blotting with NR2A and NR2B
antibodies.
Immunocytochemical Experiments
Anti-GFP antibodies (JH4030) were raised against a GFP-fusion protein.
Surface expression of GFP-NR2A and GFP-NR2B in neurons was selectively
visualized as follows (Figures 6, 8B–8D, S3A–S3C, and S3F). Surface express-
ing GFP-NR2A or GFP-NR2B was labeled by incubating live neurons in media
for 20 min at 10C with anti-GFP antibodies. Neurons were then washed twice
with ice-cold phosphate-buffered saline (PBS) containing 4% sucrose for
washout of the excess antibodies and then fixed with 4% paraformaldehyde,
4% sucrose in PBS (room temperature, 20 min). Fixed neurons were permea-
bilized with PBS containing 0.2% Triton X-100 (4C, 15 min). Coverslips were
blocked in 10% normal donkey serum in PBS at 4C overnight. Remaining
surface anti-GFP antibodies were then visualized by staining with Alexa594-
conjugated donkey anti-rabbit IgG secondary antibodies (Invitrogen), diluted
in 10% normal donkey serum in PBS. Fluorescence images were acquired
using a Photometrics CCD camera and quantified with Metamorph software
(Universal Imaging Corporation, West Chester, PA). The fluorescence intensity
averages of Alexa594-red and GFP-green signals in five dendritic regions in
indicated numbers of different neurons were measured. Red fluorescence
intensity indicative of surface receptors was divided by green fluorescence
intensity to control for GFP-NR2A and GFP-NR2B protein expression
level. Units of surface were measured as ratio of red/green fluorescence
normalized to wild-type controls. For Src family PTK-specific inhibitor treat-
ment experiments (Figures 6E–6G, S3B, S3D, and S3E), transfected cultured
cortical neurons were treated with PP2 (20 mM, Calbiochem), PP3 (20 mM, Cal-
biochem), or SU6656 (1 mM, Calbiochem) for 30 min at 37C before antibody
incubation. To visualize surface expression of endogenous NR2A, anti-NR2A
N-terminus antibodies (JH6097) were raised against the synthetic peptide
HDVTERELRNLWGPEC corresponding to amino acids 44–58 of NR2A (Fig-
ures 8A, S3D, and S3E).
Internalized GFP-NR2B in neurons was selectively visualized as follows
(Figure 6E). Surface GFP-NR2B was labeled by incubating live neurons in
media for 15 min at 10C with anti-GFP antibodies. Neurons were then
incubated in media for 15 min at 37C. Treatment with PP2 (20 mM) or PP3
(20 mM) was done for 30 min during antibody incubation and recovery. After
the incubation, neurons were washed and then fixed as mentioned above.
The remaining surface anti-GFP antibodies were blocked with goat anti-rabbit
IgG F(ab’)2 fragments (Jackson ImmunoResearch Laboratories) at room
temperature for 2.5 hr. Fixed neurons were permeabilized and then the inter-
nalized anti-GFP antibodies were visualized by staining with Alexa594-conju-
gated donkey anti-rabbit IgG secondary antibodies, diluted in 10% normal
donkey serum in PBS. Fluorescence images were acquired as described
above and the fluorescence intensity was measured. Internalization signals
were divided by surface expression signals to control for GFP-NR2B protein
expression level. Units of internalization were normalized to wild-type.
GODZ effects on NR1/NR2 localization in transfected HEK293T cells were
visualized as follows (Figures 7 and S4). The cells on coverslips were washed
twicewith PBS containing 4%sucrose at 24 hr after transfection and then fixed
with 4% paraformaldehyde, 4% sucrose in PBS (room temperature, 20 min).
Fixed cells were permeabilized with PBS containing 0.2% Triton X-100 (4C,
15 min). Coverslips were blocked in 10% normal donkey or goat serum in
PBS at 4C overnight, and then visualized using polyclonal anti-NR2A
(JH5525), polyclonal anti-NR2B (JH5523), polyclonal anti-NR1 (JH4762),
monoclonal anti-Myc (9E10), and monoclonal anti-GM130 (PharMingen) anti-
bodies, followed by incubation with Alexa594-conjugated donkey anti-rabbit
IgG and Alexa488-conjugated goat anti-mouse IgG (Invitrogen) to visualize
protein localization. The images in Figure 7 and Figure S4 are representative
of more than 20 transfected HEK293T cells. All observed transfected cells
showed similar patterns.
Neuron
Dual Palmitoylation Regulates NMDAR TraffickingThe effect of Fyn on NMDA receptor endocytosis in transfected HEK293T
cells was visualized as follows (Figure 5C). Surface expressing NR1 was
labeled by incubating transfected HEK293T in media for 1 hr at 4Cwith rabbit
polyclonal anti-NR1 N-terminus antibodies (JH2590). Then, cells were incu-
bated in media for 15 min at 37C. After the incubation, cells were washed
twice with PBS containing 4% sucrose for washout of the excess antibodies
and then fixed as above. The remaining surface anti-NR1 antibodies were
blocked with goat anti-rabbit IgG F(ab’)2 fragments (Jackson Immuno-
Research Laboratories) at room temperature for 2.5 hr. Fixed neurons were
permeabilized and blocked. Then, total expression of NR1 was labeled with
mouse monoclonal anti-NR1 antibody (s3c11). Primary antibodies were visu-
alized by staining with Alexa594-conjugated donkey anti-rabbit IgG and
Alexa488-conjugated goat anti-mouse IgG diluted in 10% normal donkey
serum in PBS as secondary antibodies. Fluorescence images were acquired
as described above and the fluorescence intensity was measured.
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